New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
Researchers developed a model that accounted for current rates of smoking cessation and relapse, life expectancy gains from smoking cessation at different ages, and how cytisine could increase smoking ...
Results that may be inaccessible to you are currently showing.